Home > Result Summaries: Compounds > Dutasteride > Result Summary for ARI40001_1

Result Summary for ARI40001_1

Result Summary
Protocol ID: ARI40001_1
Clinical Study ID: ARI40001 - Year 1
Official Title: A Multicentre, Randomised, Double-Blind, Double-Dummy, Parallel-Group Study to Compare the Efficacy of Dutasteride/GI198745 0.5mg od Versus Finasteride 5mg od for 12 Months in the Treatment of Subjects with Benign Prostatic Hyperplasia (BPH), Followed by an Optional 24 Months Open Label Phase.
Phase: Phase 3
Study Indications or Diseases:
  • Prostatic Hyperplasia
Generic Name: dutasteride
Trade/Product Name: avodart;avodart
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Andriole GL and Kirby R. Safety and Tolerability of the Dual 5 alpha Reductase Inhibitor Dutasteride in the Treatment of Benign Prostatic Hyperplasia. European Urology 44 (July 2003) 82-88
  • Abstract: Efficacy of dutasteride and finasteride for the treatment of benign prostate hyperplasia: results of the 1-year enlarged prostate international comparator study (epics). GILLING, P. J., JACOBI, G., TAMMELA, T. L., and VAN ERPS, P. Annual Scientific Meeting of the Urological Society of Australasia 2/13/2005 Melbourne; Australia